Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07250035 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy

Study acronym: CHN-CAA
StatusRecruiting
PhasePhase 3
Started2026-01-30
View on ClinicalTrials.gov ↗

Amendment history

2026-06-23
Not Yet Recruiting→Recruiting Study Status, Eligibility, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-12-20→confirmed 2026-01-30
Eligibility criteriarevised
[...] y supratentorial intracerebral hemorrhage (bleeding volume ≤30ml40ml); GCS≥8 points; NIHSS score ≤25 points; ⑥50≤age≤90 years ol [...]
Study sitesdetails revised at 1 of 1 site
2025-12-04
Active, Not Recruiting→Not Yet Recruiting Study Status, Sponsor/Collaborators, Study Design, Eligibility, Contacts/Locations v1
Trial statusActive, Not Recruiting→Not Yet Recruiting
PhaseEarly Phase 1→Phase 3
Start date2024-12-01→2025-12-20
Eligibility criteria+10 characters
Inclusion Criteria: ① Possible or very likely CAA-ICH; Within 7 days of onset; ③ Primary supratentorial intracerebral hemorrhage (bleeding volume ≤30ml); ④GCSGCS≥8 points; ⑤NIHSSNIHSS score ≤25 points; ⑥Over 50⑥50≤age≤90 years old; ⑦ Gender is not limited; ⑧ The subject or their legal representative gives informed con [...] er dysfunction is defined as ALT or AST being greater than. ⑥ Those who have received or are planning to undergo surgical [...] and have an expected survival time of less than six months; ⑧ Other conditions that significantly limit the evaluation of [...]
Collaborators+644 characters
Dongzhimen Hospital, Beijing The First Hospital of Jilin University Huairou Hospital of Traditional Chinese Medicine Weihai Wendeng District Central Hospital Nanyang First People's Hospital of Henan province Luohe Central Hospital Baofeng County People's Hospital Taoyuan County People's Hospital Qin [...]
2025-11-24
Original filing
Cerebral hemorrhage, as a serious cerebrovascular disease, has the highest disability rate and mortality rate among all types of cerebrovascular diseases .It has brought a heavy burden to society. In China, the incidence of cerebral hemorrhage is much higher than that in Europe and America, and cerebral amyloid angiopathy (CAA) is one of the causes of primary cerebral hemorrhage However, there are relatively few related studies. Therefore, the research object of this subject focuses on patients with cerebral amyloid angiopathy, in view of their high recurrence rate of vascular events and the lack of treatment methods.It aims to deeply explore the detoxification and blood stasis removal treatment plan combining traditional Chinese and Western medicine to reduce vascular events for patients.
Trial Details
NCT Number NCT07250035
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Dongzhimen Hospital, Beijing, The First Hospital of Jilin University, Huairou Hospital of Traditional Chinese Medicine, Weihai Wendeng District Central Hospital, Nanyang First People's Hospital of Henan province, Luohe Central Hospital, Baofeng County People's Hospital, Taoyuan County People's Hospital, Qingdao Huangdao District Central Hospital, Guantao County People's Hospital, Lushan County Hospital of Traditional Chinese Medicine, Yutian County Hospital of Traditional Chinese Medicine, Xianghe County Hospital of Traditional Chinese Medicine, Wuyuan County People's Hospital, Jiyuan Hospital of Traditional Chinese Medicine, Tonghua People's Hospital
Conditions Cerebral Amyloid Angiopathy
Enrollment 436 participants
Start Date 2026-01-30
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-30